Josh
@joshsavage.bsky.social
oops broken link bmccancer.biomedcentral.com/articles/10....
Selumetinib in Combination with Anti Retroviral Therapy in HIV-associated Kaposi sarcoma (SCART): an open-label, multicentre, phase I/II trial - BMC Cancer
Background Kaposi sarcoma (KS) is the commonest HIV-associated malignancy. It is caused by co-infection with Kaposi sarcoma herpesvirus (KSHV), which upregulates the MAPK pathway. The aim of the SCART...
bmccancer.biomedcentral.com
March 24, 2025 at 11:53 AM
oops broken link bmccancer.biomedcentral.com/articles/10....
a blessed 2025 indeed 🤑
January 1, 2025 at 4:17 PM
a blessed 2025 indeed 🤑
extreme lengths to justify a new year upgrade 😉. Happy New year bab
January 1, 2025 at 4:14 PM
extreme lengths to justify a new year upgrade 😉. Happy New year bab